Close

Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 38.46 -0.66 (1.69%)
Previous Close $39.12    52 Week High $18.39 
Open $38.71    52 Week Low $6.96 
Day High $38.75    P/E N/A 
Day Low $38.23    EPS $-0.58 
Volume 693,350       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 724.87 -7.33 (1%)
Previous Close $732.20    52 Week High $88.16 
Open $725.00    52 Week Low $67.88 
Day High $727.99    P/E 167.79 
Day Low $718.30    EPS $4.32 
Volume 2,608,539       

Medtronic Inc. (NYSE: MDT) Delayed: 79.25 -1.13 (1.41%)
Previous Close $80.38    52 Week High $89.27 
Open $80.04    52 Week Low $71.03 
Day High $80.35    P/E 22.51 
Day Low $78.78    EPS $3.52 
Volume 5,624,096       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 125.79 -0.37 (0.29%)
Previous Close $126.16    52 Week High $59.00 
Open $123.69    52 Week Low $32.80 
Day High $125.85    P/E N/A 
Day Low $123.21    EPS $0.00 
Volume 3,433,874       

SANOFI (NASDAQ: SNY) Delayed: 49.36 +2.75 (5.90%)
Previous Close $46.61    52 Week High $44.76 
Open $48.80    52 Week Low $36.81 
Day High $49.83    P/E N/A 
Day Low $48.65    EPS $0.00 
Volume 6,469,821